E-LIB Suche - Ergebnisse für: Hernández Boluda, Juan C.

1

Outcome of allogeneic haematopoietic stem cell transplantat..:

McLornan, Donal P. ; Malpassuti, Vittoria ; Lippinkhof‐Kozijn, Anne...
British Journal of Haematology. 190 (2020) 3 - p. 437-441 , 2020

Link: https://doi.org/10.1111/..

2

Impact of Graft-versus-Host Disease Prophylaxis on Outcomes..:

Sanz, Jaime ; Picardi, Alessandra ; Hernández Boluda, Juan C....
Biology of Blood and Marrow Transplantation. 19 (2013) 9 - p. 1387-1392 , 2013

Link: https://doi.org/10.1016/..

3

Impact of Individual Comorbidities on Survival of Patients ..:

García-Fortes, María ; Hernández-Boluda, Juan C. ; Álvarez-Larrán, Alberto...
Cancers. 14 (2022) 9 - p. 2331 , 2022

Link: https://doi.org/10.3390/..

4

Uniform graft-versus-host disease prophylaxis with posttran..:

Montoro, Juan ; Piñana, José Luis ; Hernández-Boluda, Juan C....
Bone Marrow Transplantation. 55 (2020) 11 - p. 2147-2159 , 2020

Link: https://doi.org/10.1038/..

5

Prospective Randomized Study Comparing Myeloablative Unrela..:

Sanz, Jaime ; Montoro, Juan ; Solano, Carlos...
Biology of Blood and Marrow Transplantation. 26 (2020) 2 - p. 358-366 , 2020

Link: https://doi.org/10.1016/..

6

Severe thrombocytopenia in myelofibrosis is more prevalent ..:

Masarova, Lucia ; Mesa, Ruben Anthony ; Hernández-Boluda, Juan C..
Leukemia Research. 91 (2020) - p. 106338 , 2020

Link: https://doi.org/10.1016/..

7

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the Ge..:

García-Gutiérrez, Valentín ; Gómez-Casares, María T. ; Puerta, José M....
PLOS ONE. 12 (2017) 3 - p. e0173532 , 2017

Link: https://doi.org/10.1371/..

8

Early liver complications after allogeneic haematopoietic s..:

Robin, Marie ; Gras, Luuk ; Koster, Linda...
British Journal of Haematology. 204 (2023) 2 - p. 715-718 , 2023

Link: https://doi.org/10.1111/..

9

Should we move to a genomic classification of neutrophilic ..:

Carreño-Tarragona, Gonzalo ; Álvarez-Larrán, Alberto ; Hernández-Boluda, Juan Carlos..
Blood Advances. 7 (2023) 21 - p. 6705-6706 , 2023

Link: https://doi.org/10.1182/..

10

Impact of Individual Comorbidities on Survival of Patients ..:

García-Fortes, María ; Hernández-Boluda, Juan C ; Álvarez-Larrán, Alberto...
2072-6694. , 2022

Link: http://hdl.handle.net/10..

11

Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in..:

Battipaglia, Giorgia ; Mauff, Katya ; Wendel, Lotus...
Bone Marrow Transplantation. 56 (2021) 7 - p. 1593-1602 , 2021

Link: https://doi.org/10.1038/..

12

Outcomes following second allogeneic haematopoietic cell tr..:

Nabergoj, Mitja ; Mauff, Katya ; Robin, Marie...
Bone Marrow Transplantation. 56 (2021) 8 - p. 1944-1952 , 2021

Link: https://doi.org/10.1038/..

13

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the Ge..:

García-Gutiérrez, Valentín ; Gómez-Casares, María T ; Puerta, José M...
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173532#abstract0. , 2017

Link: http://hdl.handle.net/10..

14

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the Ge..:

García-Gutiérrez, Valentín ; Gómez-Casares, María T ; Puerta, José M...
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173532#abstract0. , 2017

Link: http://hdl.handle.net/10..

15

Quantification of DNA in Plasma by an Automated Real-Time P..:

Gimeno, Concepción ; Solano, Carlos ; Latorre, José C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566127. , 2008

Link: http://www.ncbi.nlm.nih...